Department of Pathology, New York Medical College, Valhalla, New York, USA.
Department of Pathology and Clinical Laboratories, Westchester Medical Center, Valhalla, New York, USA.
Sci Rep. 2017 Apr 28;7(1):1242. doi: 10.1038/s41598-017-01349-4.
In 2014 the United States experienced a nationwide outbreak of Enterovirus D68 (EV-D68) infection. There were no confirmed cases of EV-D68 in 2015 and CDC was only aware of limited sporadic EV-D68 detection in the US in 2016. In this report, we analyzed 749 nasopharyngeal (NP) specimens collected in 2015 and 2016 from patients in the Lower Hudson Valley, New York using a previously validated EV-D68-specific rRT-PCR assay. EV-D68 was detected in none of 199 NP specimens collected in 2015, and in one of 108 (0.9%) samples from January to May and 159 of 442 (36.0%) samples from July to October 2016. Complete EV-D68 genome sequences from 22 patients in 2016 were obtained using a metagenomic next-generation sequencing assay. Comparative genome analysis confirmed that a new EV-D68 strain belonging to subclade B3, with 3.2-4.8% divergence in nucleotide from subclade B1 strains identified during the 2014 US outbreak, was circulating in the US in 2016 and caused an outbreak in the Lower Hudson Valley, New York with 160 laboratory-confirmed cases. Our data highlight the genetic variability and capacity in causing outbreak by diverse EV-D68 strains, and the necessity of awareness and more surveillance on their active circulation worldwide.
2014 年,美国发生了全国性的肠病毒 D68(EV-D68)感染疫情。2015 年没有确诊的 EV-D68 病例,而美国疾病控制与预防中心(CDC)仅在 2016 年发现了有限的散发性 EV-D68 检测。在本报告中,我们分析了 2015 年和 2016 年从纽约下哈德逊河谷地区患者中采集的 749 份鼻咽(NP)标本,使用了先前验证的 EV-D68 特异性实时 RT-PCR 检测方法。在 2015 年采集的 199 份 NP 标本中,没有检测到 EV-D68,而在 2016 年 1 月至 5 月的 108 份(0.9%)和 7 月至 10 月的 442 份(36.0%)标本中检测到 1 份。使用宏基因组下一代测序检测方法,从 2016 年的 22 名患者中获得了完整的 EV-D68 基因组序列。比较基因组分析证实,一种新的 EV-D68 株属于 B3 亚群,与 2014 年美国疫情中鉴定的 B1 亚群株在核苷酸上有 3.2-4.8%的差异,于 2016 年在美国流行,并导致纽约下哈德逊河谷地区爆发疫情,共有 160 例实验室确诊病例。我们的数据突出了不同 EV-D68 株的遗传变异性和引起暴发的能力,以及在全球范围内对其活跃传播保持警惕和加强监测的必要性。